JM Financial has retained its Buy rating on Metropolis Healthcare with a target price of Rs 734, implying 27.2% upside. The brokerage calls it the cheapest among India’s leading listed diagnostic players, citing attractive valuations, network expansion, stronger B2C growth and improving margins as key drivers.
Shanghai is rolling out new subsidies to lure offshore bond issuers into its free trade zone. This initiative aims to invigorate the currently stagnant market and position it as a leading global funding hub. Eligible bond issues will benefit from subsidies that cover legal, advisory, and banking fees, while onshore banks will also gain the ability to purchase these offshore bonds, ultimately fostering yuan internationalization and increasing foreign investments.
Tempsens Instruments made a blockbuster debut, listing at Rs 634 on the NSE, an 111% premium over its Rs 300 IPO price. The stock briefly gained further before falling over 8% from its debut level, though it remained 94% above the issue price. Analysts advised investors who missed the rally to consider buying on dips.
Tempsens Instruments has ended a 609-day drought for mainboard IPOs doubling on debut. Here is the full list of 15 IPOs that delivered listing gains above 100% since 2020.
Jefferies initiated coverage on SBI Funds Management with a Buy rating and a Rs 710 price target, implying 26% upside. The brokerage expects operating profit to grow at a 15% CAGR through FY29, supported by rising mutual fund assets, SBI’s distribution network and operating leverage. Strong B30 presence and lower operating costs further support the asset manager’s growth
Japanese government bond yields climbed, with the five-year yield hitting a record high after weak demand at a two-year auction added to selling pressure. Persistent inflation and rising energy prices also strengthened expectations of further Bank of Japan rate hikes, while investors awaited the Federal Reserve’s policy signals.
Federal Reserve Chair Kevin Warsh’s Jackson Hole speech is in focus as investors seek clues on U.S. interest rates, inflation and bond-market risks. With inflation above target and policymakers divided, markets await guidance on future policy. Warsh’s cautious approach to forward guidance will be tested amid economic and fiscal uncertainties.
Jefferies’ Christopher Wood highlights a sharp divergence in market returns: while the S&P 500 has doubled in dollar terms since early 2023, it has fallen 21% relative to gold. He warns that efforts to suppress US bond yields could weaken the dollar, boosting alternative assets such as gold and Bitcoin.
Chinese stocks were largely steady on Friday as gains in property shares offset losses in biotechnology and semiconductor stocks. The Shanghai Composite edged up 0.1%, while the CSI300 slipped 0.1%. Hong Kong equities advanced, supported by Wall Street gains and Nvidia’s upbeat outlook, which boosted global AI sentiment.
Sugar stocks rallied as domestic sugar prices surged sharply over the past month. Government data showed retail prices rising from Rs 48.18/kg on July 20 to Rs 55.70/kg on August 20, with current prices around Rs 70/kg. Balrampur Chini Mills, Dhampur Sugar, Uttam Sugar, Triveni Engineering and EID Parry were among the key gainers.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.